Top compounds associated with response to RD3


Feature Type Standardized
Nominal ANOVA
mRNA Bexarotene GDSC1000 pan-cancer AAC -0.066 0.06
mRNA JW-7-52-1 GDSC1000 pan-cancer AAC -0.097 0.06
mRNA Dasatinib GDSC1000 pan-cancer AAC -0.093 0.06
mRNA Nutlin-3a (-) GDSC1000 pan-cancer AAC -0.063 0.06
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.093 0.06
mRNA AICAR GDSC1000 pan-cancer AAC 0.058 0.06
mRNA JQ-1:vorinostat (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.061 0.06
mRNA salermide CTRPv2 pan-cancer AAC 0.084 0.07
mRNA Obatoclax Mesylate GDSC1000 pan-cancer AAC -0.063 0.07
mRNA BRD1812 CTRPv2 pan-cancer AAC 0.064 0.07
Download CSV